No press releases found.
UltraShort Nasdaq Biotechnology declares quarterly distribution of $0.1025
Seeking Alpha News (Wed, 24-Dec 10:11 AM ET)
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
ProShares Ultrashort Nasdaq Biotechnology trades on the NASDAQ stock market under the symbol BIS.
As of December 26, 2025, BIS stock price climbed to $9.19 with 13,776 million shares trading.
BIS has a market cap of $2.58 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BIS traded as high as $26.51 and as low as $8.99.
BIS has underperformed the market in the last year with a price return of -45.3% while the SPY ETF gained +16.0%. BIS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.6% and -3.7%, respectively, while the SPY returned +4.7% and +0.6%, respectively.
BIS support price is $8.83 and resistance is $9.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIS shares will trade within this expected range on the day.
